Lincoln Pharmaceuticals Balance Sheet

Financials in millions INR. Fiscal year is April - March.

Millions INR. Fiscal year is Apr - Mar.

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar '26 Mar 31, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022
Cash & Equivalents	326.57	134.14	57.47	50.52	69.34
Short-Term Investments	2,085	85.77	77.83	116.57	113.82
Trading Asset Securities	-	1,737	1,389	913.26	968.06
Cash & Short-Term Investments	2,412	1,957	1,524	1,080	1,151
Cash Growth	23.24%	28.38%	41.11%	-6.16%	21.81%
Accounts Receivable	1,614	1,664	1,618	1,363	1,159
Other Receivables	-	1.67	0.64	1.35	3.4
Receivables	2,423	2,027	1,922	1,604	1,490
Inventory	801.06	786.77	771.68	700.28	727.42
Prepaid Expenses	-	18.09	16.25	19.36	3.73
Other Current Assets	194.06	210.75	143.83	268.29	156.19
Total Current Assets	5,831	4,999	4,378	3,672	3,528
Property, Plant & Equipment	1,953	1,860	1,825	1,569	1,476
Long-Term Investments	0.03	0.03	0.04	0.03	0.03
Other Intangible Assets	9.2	4.4	3.26	2.95	3.83
Other Long-Term Assets	42.24	43.07	47.63	33.74	65.15
Total Assets	8,904	7,970	7,003	5,874	5,344
Accounts Payable	848.63	849.48	724.4	508.67	716.67
Accrued Expenses	-	99.75	90.06	82.92	70.14
Short-Term Debt	-	-	10.67	19.97	20.44
Current Portion of Long-Term Debt	44.22	-	-	-	-
Current Income Taxes Payable	16.55	-	0.71	8.82	42.77
Other Current Liabilities	201.05	112.93	96.93	101.08	54.85
Total Current Liabilities	1,110	1,062	922.77	721.45	904.86
Long-Term Unearned Revenue	64.37	53.85	36.25	47.21	45.39
Pension & Post-Retirement Benefits	17.57	7.34	0.97	1.39	-
Long-Term Deferred Tax Liabilities	135.34	130.02	114.56	79.41	64.55
Total Liabilities	1,328	1,253	1,075	849.46	1,015
Common Stock	200.3	200.3	200.3	200.3	200.3
Additional Paid-In Capital	-	646.17	646.17	646.17	646.17
Retained Earnings	-	5,969	5,182	4,279	3,580
Comprehensive Income & Other	7,376	-99.15	-100.06	-100.67	-97.7
Total Common Equity	7,576	6,717	5,928	5,025	4,329
Shareholders' Equity	7,576	6,717	5,928	5,025	4,329
Total Liabilities & Equity	8,904	7,970	7,003	5,874	5,344
Total Debt	44.22	-	10.67	19.97	20.44
Net Cash (Debt)	2,368	1,957	1,514	1,060	1,131
Net Cash Growth	20.98%	29.28%	42.76%	-6.22%	20.31%
Net Cash Per Share	118.21	97.71	75.58	52.94	56.46
Filing Date Shares Outstanding	20.03	20.03	20.03	20.03	20.03
Total Common Shares Outstanding	20.03	20.03	20.03	20.03	20.03
Working Capital	4,720	3,937	3,455	2,951	2,624
Book Value Per Share	378.34	335.34	295.98	250.86	216.12
Tangible Book Value	7,567	6,712	5,925	5,022	4,325
Tangible Book Value Per Share	377.88	335.12	295.82	250.72	215.93
Land	-	200.24	200.24	187.36	186.32
Buildings	-	626.46	602.21	580.66	478.61
Machinery	-	1,675	1,548	1,192	1,031
Construction In Progress	-	44.7	34.83	67.14	160.54